Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2013-06-06

Clinical Trial Update: Effects of Sevoflurane and Ketamine on QT in Electroconvulsive Therapy [Phase 4]

View source ↗

Summary

Phase 4 study evaluating the effects of sevoflurane and ketamine on QT interval during electroconvulsive therapy in patients with major depressive disorder; the…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Ketamine (ketamine)
  • Sevoflurane (Sevoflurane)

Snippet

Sponsor: Inonu University | Conditions: Major Depression, Electroconvulsive Therapy | Phase 4 | Status: COMPLETED